Venture-Backed Startups

Artemis Health provides data analytics and insights software to U.S. employers, advisors, and payers to optimize health benefits and reduce healthcare costs. The platform aggregates medical, pharmaceutical, and claims data to help benefits teams make decisions that improve outcomes and lower spending.

3 investors

Artera provides AI-powered voice and text communication agents for healthcare providers to improve patient engagement and streamline coordination of care. The platform helps healthcare organizations including clinics and hospital networks communicate more efficiently with patients throughout their care journey.

3 investors

Artera develops AI-powered diagnostic tests that analyze patient biopsy images to predict therapeutic response in cancer care. The company enables personalized treatment decisions and shared decision-making between clinicians and patients, beginning with localized prostate cancer.

1 investor

Arterys provides AI clinical applications for medical imaging that integrate directly into existing PACS and EHR systems to assist physicians with diagnosis and treatment decisions. The platform is cloud-based and designed for radiology workflows in healthcare settings.

1 investor

Arthena operates a financial fund that enables high-net-worth individuals to invest in art by using statistical models trained on auction data to identify and purchase artworks expected to appreciate with low correlation to traditional asset classes.

2 investors

Arthur develops an AI-powered platform that enables organizations to build and deploy immersive workflows and experiences combining synchronous and asynchronous collaboration. The platform features AI agents that guide employees through critical workflows such as onboarding, decision-making meetings, and organizational discovery, while maintaining enterprise security and data privacy.

1 investor

Arthur provides AI performance monitoring, optimization, explainability, and bias mitigation solutions for enterprise customers deploying artificial intelligence. The company helps organizations monitor and improve their AI systems to maximize performance and mitigate risks.

3 investors

Enterprise-grade Generative AI platform helping enterprises unlock business value while maintaining data privacy.

1 investor

Artie provides a data replication platform built on change data capture (CDC) technology, enabling real-time data movement with sub-minute latency and zero data loss. The platform serves engineering teams building data pipelines who need reliable, low-maintenance data ingestion without schema management complexity.

6 investors

Artielle Immunotherapeutics develops DRhQ, a therapeutic platform targeting CD74 receptors to treat neuroinflammatory conditions like progressive multiple sclerosis and advanced cancers. The company's approach blocks macrophage migration inhibitory factor signaling to redirect immune cell activity away from CNS injury sites.

1 investor

Artifact is a collaborative ECAD (electrical CAD) design tool for managing complex electrical systems. It enables teams in design, manufacturing, and procurement to collaborate in real-time while automatically generating harness drawings, pin tables, and BOMs, with support for version control, electrical verification, and multi-layered system views.

2 investors

Artifact captures and preserves personal stories and life narratives for families and individuals. The platform allows people to create digital records of meaningful relationships and histories that might otherwise be lost.

1 investor

Artificial provides a configurable software platform for specialty and reinsurance brokers and carriers to manage placement and underwriting workflows through integrated data tools and proprietary technology.

1 investor

AI Underwriting Consortium certifies and insures AI agents against failure, helping enterprises confidently adopt AI systems through standardized security audits and insurance coverage.

1 investor

Societies creates AI-powered simulations of human personas and attitudes to enable market research, audience analysis, and consumer insights at scale. The platform synthesizes real-world audience data with artificial intelligence to help businesses understand decision-makers and validate strategies.

3 investors

Artillery is a performance testing toolkit that provides load testing, Playwright-based end-to-end testing, and production monitoring capabilities for web applications and APIs. It serves development and DevOps teams that need to ensure application performance and reliability at scale.

1 investor

Artis BioSolutions develops synthetic DNA and provides integrated manufacturing services for genetic medicine and advanced therapeutic modalities, including cell therapy, gene therapy, mRNA, gene editing, and vaccines. The company serves genetic medicine developers seeking to accelerate clinical development and GMP manufacturing within a single quality framework.

1 investor

Artisan builds an AI-powered platform that consolidates fragmented work software tools and automates repetitive workflows through AI collaborators. The platform initially focuses on outbound sales but aims to expand across industries including customer success, recruiting, and enterprise operations.

3 investors

Artos provides AI-powered software tools for Chemistry, Manufacturing, and Controls (CMC) teams in the pharmaceutical industry to draft, manage, and quality-check regulatory documentation. The platform uses specialized AI systems designed to handle dense tabular data and non-standard formats common in regulatory Module 3 documents.

2 investors

Artsy is a global online art marketplace that connects collectors with artists, galleries, and auction houses. The platform offers discovery, curation, and transaction tools for buying and selling original artworks across contemporary and modern art categories.

3 investors

ShipArty builds IoT-enabled temperature-controlled containers and software platform to reduce cold chain spoilage for medicines, vaccines, and other temperature-sensitive products. The company offers reusable, sustainable alternatives to single-use cooling systems for pharmaceutical and healthcare supply chains.

1 investor

Arva provides financial crime compliance software for compliance teams in financial services, helping them work more efficiently on detection and monitoring tasks.

2 investors

Arvinas is a clinical-stage biopharmaceutical company developing PROTAC protein degrader therapies for oncology and neurology. The company focuses on discovering and developing novel investigational drugs for patients with limited or ineffective treatment options.

4 investors

Arvist provides an AI platform for warehouse operations that integrates with existing systems to automate claims management, detect errors, and improve supply chain efficiency. The company serves warehouse and operations teams seeking to optimize workflows without replacing existing infrastructure.

4 investors